Affordability decision rules: a systematic review and framework for categorising budget impact thresholds across health systems

This publication has 23 references indexed in Scilit:

• Systematic Literature Review of Guidelines on Budget Impact Analysis for Health Technology Assessment
  Applied Health Economics and Health Policy, 2021
• Incorporating Affordability Concerns Within Cost-Effectiveness Analysis for Health Technology Assessment
  Value in Health, 2019
• PHP302 - HOW AFFORDABILITY IS CONSIDERED FOR PRICING POLICIES?
  Value in Health, 2018
• The ICER Value Framework: Integrating Cost Effectiveness and Affordability in the Assessment of Health Care Value
  Value in Health, 2018
• Resolving the “Cost-Effective but Unaffordable” Paradox: Estimating the Health Opportunity Costs of Nonmarginal Budget Impacts
  Value in Health, 2018
• The use of budget impact analysis in the economic evaluation of new medicines in Australia, England, France and the United States: relationship to cost-effectiveness analysis and methodological challenges
  The European Journal of Health Economics, 2017
• A Comparison of The Nice Highly Specialised Technology (HST) Programme with Assessment By The National Authority For Health (HAS; France), And The Federal Joint Committee (G-BA; Germany)
  Value in Health, 2017
• Defining and Measuring the Affordability of New Medicines: A Systematic Review
  PharmacoEconomics, 2017
• Comparison of Orphan Drug Market Access in A Sample of EU Countries, Ausralia, Canada and US
  Value in Health, 2016
• Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force
  Value in Health, 2014